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Hypersensitivity pneumonitis (HP) is a pulmonary
disease with symptoms of dyspnea and cough
resulting from repeated inhalation of an antigen
to which the patient has been previously sensi-
tized.1 We report a HP case, due to pigeon
breeding, complicated with acute respiratory dis-
tress syndrome (ARDS) after bronchoscopy. ARDS
development in HP course is extremely rare. We
aimed to present this rare manifestation and toElsevier Ltd. All rights reserv
s-tirma Hastanesi, Go¨g˘u¨s
Erzurum, Turkey. Fax:
u.tr (M. Akgun).discuss possible explanation for ARDS development
in the case.Case report
A 36-year old non-smoking man without any pre-
existing disease was admitted to our department
because of shortness of breath, cough, streaky
sputum, fatigue, fever and night sweats for 2
months. He had been treated with a macrolide
antibiotic twice daily as a community acquired
pneumonia 2 weeks ago. However his symptoms
had not substantially improved. Respiratory symp-
toms had aggravated 24 h prior to the hospital
admission, during his daily chores. His medical
history included pigeon breeding (13 pigeons) onlyed.
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Figure 2 HRCT imagings. (a, b, c) On admission, (d, e, f)
follow-up after 5 months.
M. Akgun et al.1196for the preceding 2 months. Physical examination
revealed tachypnea (22 per min) and diffuse
fine bibasilar crackles on auscultation. On hospital
admission the blood gas values were: pH ¼ 7:52;
arterial oxygen tension (PaO2) 64mmHg
(FiO2 ¼ 0:21), arterial carbon dioxide tension
(PaCO2) 35.9mmHg, bicarbonate (HCO3) 28.0mEq/l
and percent of arterial oxygen saturation (SaO2)
94%. Pulmonary function tests revealed the follow-
ing (as % predicted): FVC 59%, FEV1 64%, FEV1/FVC
92%, FEF25–75 94% and PEF 65%. Chest X-ray
revealed bilateral reticulo-nodular opacities (Fig.
1(a)). HRCT showed bilateral patchy ground-glass
opacities, which were more prominent mid-to-
upper lung zones and bilateral pleural effusion
(Figs. 2(a)–(c)). Routine laboratory tests were
normal, except for mild elevation of LDH (680U/
ml, cut-off levels 250–500U/ml) and moderate
elevation of CRP (3.3mg/dl, upper limit 0.5mg/
dl). On day 3 of admission, the patient underwent
bronchoscopy, and bronchoalveolar lavage (BAL)
and transbronchial lung biopsy (TBLB) were per-
formed. Examination of BAL fluid revealed lympho-
cytosis (43.2%), increased mast cells (1.8%) and
decreased CD4+-to-CD8+ ratio (0.74). Diagnosis of
HP was confirmed by histopathological examination
of TBLB specimen. A day later the patient suffered
increased dyspnea. A new chest X-ray showed more
diffuse alveolar signs involved both lungs Fig. 1(b).
Respiratory dyspnea and blood gas values wor-
sened: pH 7.38, PaO2 26.3mmHg (FiO2 ¼ 0:21),
PaCO2 28.4mmHg, HCO3 27.0mEq/l, SaO2 41.6%.
There was no clinical sign or laboratory findings ofFigure 1 Chest X-ray imaging of the patient. (a) On
admission, (b) during respiratory failure, (c) follow-up
after 5 months.an infection. The patient underwent non-invasive
mechanical ventilation therapy for 5 h, followed by
emergency tracheal intubation for acute respira-
tory failure. Steroid (prednisone) therapy (1mg/kg
per day i.v.) was started immediately. The ARDS
required mechanic ventilation (IPPV-PEEP) for 7
days. The patient was extubated and admitted to
the medical respiratory unit. Steroid therapy was
tapered and continued. The patient was discharged
after stabilization. He was reviewed at 2 and 5
months. Follow-up chest X-ray and HRCT after 5
months revealed almost normal findings (Figs. 1(c),
2(d)–(f)).Discussion
Respiratory symptoms of HP may occur in acute,
subacute, or chronic stages. The type of presenta-
tion influenced by host susceptibility factors, the
nature of the biologic dust or avian antigen, the
intensity and frequency of exposure, the severity of
inflammatory response to the pulmonary injury, and
the sequelae of the immunologically mediated
inflammation. On occasion, acute HP can present
with fulminant acute respiratory failure, which is
clinically and radiographically indistinguishable
from ALI/ARDS.2 However, the clinical course of
HP complicating with ARDS is very rare.
ARDS may result from an intervening infection or
a second exposure with same or different antigen.
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Hypersensitivity pneumonitis complicated with ARDS 1197There is only an ARDS case, in the English
literature, after double extrinsic exposure HP.3 In
our case, there was no relevant evidence elucidat-
ing the case. The remaining possible explanation
for this case was only bronchoscopic interventions
including TBLB and BAL. The bronchoscopic pro-
cesses may be an insult that triggered an inflam-
matory response leading to respiratory failure.
In a retrospective study including 4273 broncho-
scopy, respiratory failure occurred in 11 patients
or 0.02% of procedures.4 But that study did
not state the diseases associated with respiratory
failure. Some diseases, for example HP, may
have more tendencies to respiratory failure than
others.
HP rarely needs intensive care treatment with
tracheal intubation and mechanical ventilation;
patients often require only removal of the source
antigen inhalation and systemic long-term steroidtherapy.5 ARDS management is mainly based on
mechanical ventilation. Although steroid treatment
in ARDS is still controversial, it, in such cases, may
be lifesaving.References
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